logo

Scholar Rock Holding Corp (SRRK)



Trade SRRK now with
  Date
  Headline
6/17/2022 10:12:06 AM Scholar Rock Shares Surge 17%
6/17/2022 7:33:25 AM Scholar Rock Announces $205 Mln Registered Direct Offering
6/17/2022 7:06:30 AM Scholar Rock Announces Positive Phase 2 Topaz Trial Extension Data
5/17/2022 11:56:22 AM Wedbush Is Raising Scholar Rock Holding Corp (SRRK) FY22 Estimate To -2.80 From -4.34
5/17/2022 11:56:08 AM Wedbush Is Increasing Scholar Rock Holding Corp (SRRK) Q4 22 Estimate To -0.57 From -1.05
5/17/2022 11:55:51 AM Wedbush Is Raising Scholar Rock Holding Corp (SRRK) Q3 22 Estimate To -0.97 From -0.98
5/17/2022 11:55:33 AM Wedbush Is Increasing Scholar Rock Holding Corp (SRRK) Q2 22 Estimate To -1.17 From -1.23
5/17/2022 11:55:05 AM Wedbush Reiterates Scholar Rock Holding Corp (SRRK) At Outperform With $33 Down From $50 Price Target
3/7/2022 4:49:00 PM Wedbush Is Increasing Scholar Rock Holding Corp (SRRK) FY22 Estimate To -4.34 From -4.52
3/7/2022 4:48:41 PM Wedbush Is Raising Scholar Rock Holding Corp (SRRK) Q4 22 Estimate To -1.05 From -1.22
3/7/2022 4:48:23 PM Wedbush Is Raising Scholar Rock Holding Corp (SRRK) Q3 22 Estimate To -0.98 From -1.12
3/7/2022 4:48:05 PM Wedbush Is Cutting Scholar Rock Holding Corp (SRRK) Q2 22 Estimate To -1.23 From -1.08
3/7/2022 4:47:47 PM Wedbush Is Lowering Scholar Rock Holding Corp (SRRK) Q1 22 Estimate To -1.14 From -1.10
3/7/2022 4:46:51 PM Wedbush Reiterates Scholar Rock Holding Corp (SRRK) At Outperform With $50 Price Target
3/7/2022 7:09:47 AM Scholar Rock FY Net Loss $131.8 Mln Or $3.59/shr Vs Net Loss Of $86.5.0 Mln Or $2.81/shr Prior Year
11/9/2021 8:13:01 AM Scholar Rock Q3 Net Loss $37.5 Mln Or $1.02/shr Vs Net Loss Of $23.6 Mln Or $0.79/shr Prior Year
10/3/2021 9:32:38 AM Scholar Rock To Present Apitegromab TOPAZ Phase 2 Pharmacologic Data
8/16/2021 4:08:52 PM Scholar Rock Appoints Caryn Parlavecchio As Chief Human Resources Officer
6/18/2021 8:07:41 AM Scholar Rock To Present Apitegromab TOPAZ Phase 2 Trial Results At 2021 European Academy Of Neurology Congress
6/7/2021 7:57:19 AM Scholar Rock To Present Apitegromab Clinical Data From TOPAZ Phase 2 Trial In Type 2 & 3 Spinal Muscular Atrophy At SMA